PAOG Announces Acquisition of Resprx Entering $200B Biopharma Market

Sandusky, Ohio–(Newsfile Corp. – July 30, 2020) – PAO Group, Inc. (OTC Pink: PAOG) today announced the acquisition of RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). Figure 1: RespRxTo view an enhanced version of Figure 1, please visit: is a treatment for Chronic Obstructive Pulmonary Disease (COPD) under development that is derived from a patented cannabis extraction method – U.S. Patent No. 9,199,960 entitled, "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS …
Source: Kaly
PAOG Announces Acquisition of Resprx Entering 0B Biopharma Market

The Motley Fool
Contributor at
The Motley Fool is dedicated to helping the world invest — better. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, mutual funds, and premium investing services.

In all we do, we take a different approach.

We believe – and have proven over decades – that the individual investor can beat the market.

We believe that anyone can do it, even if they don’t have a lot of time or money to devote to investing.

We believe in a long-term outlook, helping people build wealth over time.

We believe that the person best positioned to take care of your financial future is you.

And we work tirelessly on behalf of our hundreds of thousands of members who are enjoying the opportunities that come with having enough money to do the things that matter to them.

While we are headquartered in Alexandria, Va., The Motley Fool advocates for the individual investor around the globe with offices in the UK, Australia, Canada, Singapore, and Germany.

Related News